1,586 results on '"Stebbing, Justin"'
Search Results
2. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
3. CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth
4. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma
5. The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS
6. A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
7. Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma
8. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
9. A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
10. The mutational landscape of the adult healthy parous and nulliparous human breast
11. Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial
12. Comparison of phenomics and cfDNA in a large breast screening population: the Breast Screening and Monitoring Study (BSMS)
13. Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy
14. A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data
15. Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas
16. CCR5 and CCL5 in metastatic colorectal cancer
17. PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38MAPK signalling
18. Identification of an immune gene-associated prognostic signature in patients with bladder cancer
19. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report
20. Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients
21. Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer
22. Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
23. Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma
24. LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).
25. The LMTK-family of kinases: Emerging important players in cell physiology and pathogenesis
26. Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial
27. Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients
28. The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer
29. Genes and Race in Colon Cancer
30. CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth
31. Uncovering the Blueprint of Aging: How Aging Causes Late-Life Disease
32. Disparities in the consensus for treatment of chemotherapy-induced thrombocytopenia
33. LMTK3 inhibition affects microtubule stability
34. Correction to: LMTK3 inhibition affects microtubule Stability
35. PIK3C[delta] expression by fibroblasts promotes triple-negative breast cancer progression
36. Novel immunotherapeutic drugs for the treatment of lung cancer
37. Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
38. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
39. Genes and Race in Colon Cancer.
40. Afatinib treatment in a lung adenocarcinoma patient harboring a rare EGFR L747P mutation
41. CNS penetration of potential anti-COVID-19 drugs
42. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours
43. Profiling circulating tumour cells and cell free DNA together in metastatic colon cancer
44. The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention
45. Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease
46. Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma
47. Figure S4 from The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer
48. Data from Prognostic Role of Lemur Tyrosine Kinase-3 Germline Polymorphisms in Adjuvant Gastric Cancer in Japan and the United States
49. Supplementary Table 1 from Prognostic Role of Lemur Tyrosine Kinase-3 Germline Polymorphisms in Adjuvant Gastric Cancer in Japan and the United States
50. Data from The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.